SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-017602
Filing Date
2022-11-14
Accepted
2022-11-14 08:15:49
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmbr-20221114x8k.htm   iXBRL 8-K 33380
2 EX-99.1 tmbr-20221114xex99d1.htm EX-99.1 220590
  Complete submission text file 0001558370-22-017602.txt   394030

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmbr-20221114.xsd EX-101.SCH 3735
4 EX-101.DEF tmbr-20221114_def.xml EX-101.DEF 2731
5 EX-101.LAB tmbr-20221114_lab.xml EX-101.LAB 17364
6 EX-101.PRE tmbr-20221114_pre.xml EX-101.PRE 10166
8 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20221114x8k_htm.xml XML 4910
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 221380523
SIC: 2834 Pharmaceutical Preparations